🔎 Trials Near Me

Nyumbani › Uzito Kupita Kiasi › Texas › Houston

Majaribio ya kliniki ya Uzito Kupita Kiasi katika Houston, TX

Masomo 33 ya Uzito Kupita Kiasi yanatafuta washiriki katika vituo vya Houston na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

InaajiriHatua 2
  • Juno Research /ID# 282413, Houston
  • PlanIt Research /ID# 282204, Houston
  • JCCT - Juno Bellaire /ID# 282263, Bellaire · Mi 7 mbali
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

InaajiriHatua 3
  • PlanIt Research, PLLC, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07533175

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

InaajiriHatua 3
  • DM Clinical, Houston
Umri 8 hadi 18 · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

InaajiriHatua 3
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

InaajiriHatua 3
  • Biopharma Informatic, LLC, Houston
  • Care Access - Houston - Clinical Trials Center by Walmart & Care Access, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

InaajiriHatua 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07595549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

InaajiriHatua 3
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • na zaidi ya 1
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

InaajiriHatua 3
  • Juno Research, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

InaajiriHatua 3
  • Juno Research, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

InaajiriHatua 3
  • Research Site, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

InaajiriHatua 3
  • Biopharma Informatic, LLC, Houston
  • Cardiovascular Specialists of Willowbrook, Houston
  • PlanIt Research, PLLC, Houston
  • na zaidi ya 2
Umri 45 hadi 99 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

InaajiriHatua 3
  • The University of Texas Health Science Center at Houston, Bellaire · Mi 7 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

InaajiriHatua 3
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · Mi 7 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

InaajiriHatua 2
  • PlanIt Research, PLLC, Houston
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07589608

Semaglutide for Post-Smoking Cessation Weight Management

InaajiriHatua 2Wajitolea wenye afya wanakaribishwa
  • The University of Texas Health Science Center at Houston, Houston
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

InaajiriHatua 3
  • AURORA-2 Clinical Site, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

InaajiriHatua 3
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

InaajiriHatua 2
  • Juno Research, Houston
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

InaajiriHatua 3
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · Mi 7 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

InaajiriHatua 3Wajitolea wenye afya wanakaribishwa
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

InaajiriHatua 2
  • PlanIt Research, PLLC, Houston
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

InaajiriHatua 2
  • Biopharma Informatic, LLC, Houston
  • PlanIt Research, PLLC, Houston
  • Research Physicians Network, LLC, Houston
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT07215559

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

InaajiriHatua 4
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · Mi 7 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT06857942

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

InaajiriHatua 3
  • JCCT- Juno Northwest Houston, Houston
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · Mi 7 mbali
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

InaajiriHatua 3
  • Kailera Clinical Site, Bellaire · Mi 7 mbali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

InaajiriHatua 3
  • JCCT- Juno Northwest Houston, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · Mi 7 mbali
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT07684144

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

InaajiriHatua 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 27 Ago 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

InaajiriHatua 3
  • Research Site, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

InaajiriHatua 3
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
Umri 18 hadi 79 · Jinsia zote · Imesasishwa 10 Ago 2026 · NCT07654361

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

InaajiriHatua 2
  • Baylor College of Medicine, Houston
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Jan 2026 · NCT06273072

Majaribio ya Uzito Kupita Kiasi katika miji mingine

Masomo mengine katika Houston

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.